Nucleic Acids Research, Vol 24, Issue 18 3538-3545, Copyright © 1996 by Oxford University Press
E Rubin and AA Levy
A mathematical model and a computer simulation were used to study PCR
specificity. The model describes the occurrences of non-targeted PCR
products formed through random primer-template interactions. The PCR
simulation scans DNA sequence databases with primers pairs. According to
the model prediction, PCR with complex templates should rarely yield
non-targeted products under typical reaction conditions. This is surprising
as such products are often amplified in real PCR under conditions optimized
for stringency. The causes for this 'PCR paradox' were investigated by
comparing the model predictions with simulation results. We found that
deviations from randomness in sequences from real genomes could not explain
the frequent occurrence of non-targeted products in real PCR. The most
likely explanation to the 'PCR paradox' is a relatively high tolerance of
PCR to mismatches. The model also predicts that mismatch tolerance has the
strongest effect on the number of non-targeted products, followed by primer
length, template size and product size limit. The model and the simulation
can be utilized for PCR studies, primer design and probing DNA uniqueness
and randomness.
ARTICLES
A mathematical model and a computerized simulation of PCR using complex templates
Department of Plant Genetics, Weizmann Institute of Science, Rehovot, Israel.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. D. Gans and M. Wolinsky Improved assay-dependent searching of nucleic acid sequence databases Nucleic Acids Res., July 1, 2008; 36(12): e74 - e74. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schamhart, J. Swinnen, K.-H. Kurth, A. Westerhof, R. Kusters, H. Borchers, and C. Sternberg Numeric Definition of the Clinical Performance of the Nested Reverse Transcription-PCR for Detection of Hematogenous Epithelial Cells and Correction for Specific mRNA of Non-Target Cell Origin as Evaluated for Prostate Cancer Cells Clin. Chem., September 1, 2003; 49(9): 1458 - 1466. [Abstract] [Full Text] [PDF] |
||||

